CAMP CAMP4 Therapeutics Corporation

NASDAQ
$4.24

CAMP4 Therapeutics Corporation (CAMP) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with CAMP's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 1 buyer in the last 30 days 4 buyers in the last 90 days 2 sellers in the last 90 days
Insiders buying
4
5 transactions
Insiders selling
2
6 transactions
Purchases
$99.1K
46,031 shares
Sales
$2.5M
593,613 shares
Net activity
-$2.4M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $2.5M 6 transactions · 593,613 shares

Largest single sale: $1.6M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: August 31, 2026 , by Gold Kelly .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Gold Kelly Chief Financial Officer Buy 10,000 $3.96 $39.6K 10,000
Schwab Andrew J. Director Sell 400,000 $4.04 $1.6M 2,033,270 −16.4% of holding
Schwab Andrew J. Director Sell 10 $4.50 $45 2,433,270 −0% of holding
Schwab Andrew J. Director Sell 32,018 $4.50 $144.1K 2,433,280 −1.3% of holding
Schwab Andrew J. Director Sell 114,700 $4.54 $520.7K 2,465,298 −4.4% of holding
Schwab Andrew J. Director Sell 45,147 $4.76 $214.9K 2,579,998 −1.7% of holding
Tardiff Daniel Chief Scientific Officer Sell 1,738 $4.76 $8.3K None left
Young Richard A Director Buy 16,378 $1.65 $27.0K 186,388
Maricich Yuri Chief Medical Officer Buy 6,551 $1.65 $10.8K 12,611
Mandel-Brehm Josh Chief Executive Officer Buy 6,551 $1.65 $10.8K 284,968
Gold Kelly Chief Financial Officer Buy 6,551 $1.65 $10.8K 74,428

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.